{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:47:18Z","timestamp":1792198038670,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.4158\/ep161679.ra","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T10:07:35Z","timestamp":1495534055000},"page":"971-978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Diabetic Ketoacidosis: A Common Debut of Diabetes Among African Americans With Type 2 Diabetes"],"prefix":"10.1016","volume":"23","author":[{"given":"Priyathama","family":"Vellanki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo E.","family":"Umpierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP161679.RA_bb0010","unstructured":"Control CfD. Number of Hosptal Discharged with Diabetic Ketoacidosis (DKA) as First-Listed Diagnosis, United States, 1988\u20132009. Available at: http:\/\/www.cdc.gov\/diabetes\/statistics\/dkafirst\/fig1.htm."},{"key":"10.4158\/EP161679.RA_bb0015","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/archinte.164.17.1925","article-title":"Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences","volume":"164","author":"Newton","year":"2004","journal-title":"Arch Inter Med"},{"key":"10.4158\/EP161679.RA_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9343(96)00076-9","article-title":"The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults","volume":"101","author":"Westphal","year":"1996","journal-title":"Am J Med"},{"key":"10.4158\/EP161679.RA_bb0025","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.diabres.2012.05.004","article-title":"Characteristics of diabetic ketoacidosis in Chinese adults and adolescents -- a teaching hospital-based analysis","volume":"97","author":"Tan","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.4158\/EP161679.RA_bb0030","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1464-5491.2008.02461.x","article-title":"Ketoacidosis occurs in both Type 1 and Type 2 diabetes--a population-based study from Northern Sweden","volume":"25","author":"Wang","year":"2008","journal-title":"Diabet Med"},{"key":"10.4158\/EP161679.RA_bb0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM198702053160601","article-title":"Maturity-onset diabetes of youth in black Americans","volume":"316","author":"Winter","year":"1987","journal-title":"N Engl J Med"},{"key":"10.4158\/EP161679.RA_bb0040","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1210\/jc.2003-030180","article-title":"Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes","volume":"88","author":"Maldonado","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161679.RA_bb0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2337\/diabetes.53.3.645","article-title":"Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance","volume":"53","author":"Mauvais-Jarvis","year":"2004","journal-title":"Diabetes"},{"key":"10.4158\/EP161679.RA_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pcd.2011.11.001","article-title":"Do obese children with diabetic ketoacidosis have type 1 or type 2 diabetes?","volume":"6","author":"Low","year":"2012","journal-title":"Prim Care Diabetes"},{"key":"10.4158\/EP161679.RA_bb0055","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archinte.1997.00440270117011","article-title":"Hyperglycemic crises in urban blacks","volume":"157","author":"Umpierrez","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP161679.RA_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1464-5491.2001.00395.x","article-title":"Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function","volume":"18","author":"McFarlane","year":"2001","journal-title":"Diabet Med"},{"key":"10.4158\/EP161679.RA_bb0065","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2337\/diab.44.7.790","article-title":"Diabetic ketoacidosis in obese African-Americans","volume":"44","author":"Umpierrez","year":"1995","journal-title":"Diabetes"},{"key":"10.4158\/EP161679.RA_bb0070","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0035-9203(68)90138-7","article-title":"\u201cTemporary diabetes\u201d in adult Nigerians","volume":"62","author":"Adadevoh","year":"1968","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.4158\/EP161679.RA_bb0075","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/bmj.2.5554.747","article-title":"Diabetes in the tropics","volume":"2","author":"Dodu","year":"1967","journal-title":"Br Med J."},{"key":"10.4158\/EP161679.RA_bb0080","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diab.43.6.741","article-title":"GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes","volume":"43","author":"Banerji","year":"1994","journal-title":"Diabetes"},{"key":"10.4158\/EP161679.RA_bb0085","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2337\/diacare.22.9.1517","article-title":"Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis","volume":"22","author":"Umpierrez","year":"1999","journal-title":"Diabetes Care"},{"key":"10.4158\/EP161679.RA_bb0090","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1210\/jc.2003-031656","article-title":"Ketosis-prone diabetes--a new subgroup of patients with atypical type 1 and type 2 diabetes?","volume":"88","author":"Kitabchi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161679.RA_bb0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00125-001-0739-8","article-title":"Adult-onset idiopathic Type I or ketosis-prone Type II diabetes: evidence to revisit diabetes classification","volume":"45","author":"Sobngwi","year":"2002","journal-title":"Diabetologia"},{"key":"10.4158\/EP161679.RA_bb0100","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2337\/diacare.24.6.1014","article-title":"Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience","volume":"24","author":"Pinero-Pilona","year":"2001","journal-title":"Diabetes Care"},{"key":"10.4158\/EP161679.RA_bb0105","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1001\/archinte.159.19.2317","article-title":"New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity","volume":"159","author":"Balasubramanyam","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP161679.RA_bb0110","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.2337\/dc16-0406","article-title":"Randomized Controlled Study of Metformin and Sitagliptin on Long-Term Normoglycemia Remission in African American Patients With Hyperglycemic Crises","volume":"39","author":"Vellanki","year":"2016","journal-title":"Diabetes Care"},{"key":"10.4158\/EP161679.RA_bb0115","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.2337\/diacare.26.8.2469","article-title":"Ethnic differences in beta-cell functional reserve and clinical features in patients with ketosis-prone diabetes","volume":"26","author":"Maldonado","year":"2003","journal-title":"Diabetes Care"},{"key":"10.4158\/EP161679.RA_bb0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jdiacomp.2006.01.005","article-title":"Comparison of type 1, type 2, and atypical ketosis-prone diabetes at 4 years of diabetes duration","volume":"20","author":"Ramos-Rom\u00e1n","year":"2006","journal-title":"J Diabetes Complications"},{"key":"10.4158\/EP161679.RA_bb0125","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1464-5491.2004.01249.x","article-title":"Clinical characteristics and outcomes of diabetic ketoacidosis in Pakistani adults with Type 2 diabetes mellitus","volume":"21","author":"Jabbar","year":"2004","journal-title":"Diabet Med"},{"key":"10.4158\/EP161679.RA_bb0130","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2337\/diacare.20.4.479","article-title":"Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises","volume":"20","author":"Umpierrez","year":"1997","journal-title":"Diabetes Care"},{"key":"10.4158\/EP161679.RA_bb0135","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","article-title":"Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multi-centre randomised parallel-group trial","volume":"371","author":"Weng","year":"2008","journal-title":"Lancet"},{"key":"10.4158\/EP161679.RA_bb0140","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.2337\/dc14-0893","article-title":"Liraglutide and the preservation of pancreatic beta-cell function in early type 2 diabetes: the LIBRA trial","volume":"37","author":"Retnakaran","year":"2014","journal-title":"Diabetes Care"},{"key":"10.4158\/EP161679.RA_bb0145","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2337\/dc11-0291","article-title":"Effects of exenatide on measures of beta-cell function after 3 years in metformin-treated patients with type 2 diabetes","volume":"34","author":"Bunck","year":"2011","journal-title":"Diabetes Care"},{"key":"10.4158\/EP161679.RA_bb0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.0.CO;2-W","article-title":"UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group","volume":"15","author":"Matthews","year":"1998","journal-title":"Diabet Med"},{"key":"10.4158\/EP161679.RA_bb0155","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2337\/db12-0624","article-title":"Pathogenesis of A-b+ ketosis-prone diabetes","volume":"62","author":"Patel","year":"2013","journal-title":"Diabetes"},{"key":"10.4158\/EP161679.RA_bb0160","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2337\/dc09-1687","article-title":"Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemia remission","volume":"33","author":"Gosmanov","year":"2010","journal-title":"Diabetes Care"},{"key":"10.4158\/EP161679.RA_bb0165","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/dc09-1369","article-title":"Lack of lipotoxicity effect on {beta}-cell dysfunction in ketosis-prone type 2 diabetes","volume":"33","author":"Umpierrez","year":"2010","journal-title":"Diabetes Care"},{"key":"10.4158\/EP161679.RA_bb0170","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jaad.2005.03.057","article-title":"Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection","volume":"54","author":"Chiou","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.4158\/EP161679.RA_bb0175","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/000992289903801105","article-title":"Genital herpes and diabetic ketoacidosis: a patient report","volume":"38","author":"DeOcampo","year":"1999","journal-title":"Clinical Pediatr (Phila)"},{"key":"10.4158\/EP161679.RA_bb0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0168-8227(91)90037-E","article-title":"Diabetic ketoacidosis precipitated by genital herpes infection","volume":"13","author":"Tesfaye","year":"1991","journal-title":"Diabetes Res Clin Pract"},{"key":"10.4158\/EP161679.RA_bb0185","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2004.03.020","article-title":"Insulin resistance and insulin secretion in chronic hepatitis C virus infection","volume":"41","author":"Narita","year":"2004","journal-title":"J Hepatol"},{"key":"10.4158\/EP161679.RA_bb0190","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1001\/jama.299.23.2770","article-title":"Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-saharan africans","volume":"299","author":"Sobngwi","year":"2008","journal-title":"JAMA"},{"key":"10.4158\/EP161679.RA_bb0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.diabet.2016.05.004","article-title":"Relationship between HHV8 infection markers and insulin sensitivity in ketosis-prone diabetes","volume":"43","author":"Nguewa","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.4158\/EP161679.RA_bb0200","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.2337\/dc06-0749","article-title":"Accuracy and predictive value of classification schemes for ketosis-prone diabetes","volume":"29","author":"Balasubramanyam","year":"2006","journal-title":"Diabetes Care"},{"key":"10.4158\/EP161679.RA_bb0205","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/diab.45.3.337","article-title":"Long-term normoglycemic remission in black newly diagnosed NIDDM subjects","volume":"45","author":"Banerji","year":"1996","journal-title":"Diabetes"},{"key":"10.4158\/EP161679.RA_bb0210","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2337\/diab.44.4.466","article-title":"Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatment","volume":"44","author":"Banerji","year":"1995","journal-title":"Diabetes"},{"key":"10.4158\/EP161679.RA_bb0215","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.metabol.2010.01.009","article-title":"Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of \u201cA-b+\u201d ketosis-prone diabetes based on long-term b-cell function, human leukocyte antigen class II alleles, and sex predilection","volume":"59","author":"Nalini","year":"2010","journal-title":"Metabolism"},{"key":"10.4158\/EP161679.RA_bb0220","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.2337\/dc12-2328","article-title":"Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes","volume":"36","author":"Brooks-Worrell","year":"2013","journal-title":"Diabetes Care"},{"key":"10.4158\/EP161679.RA_bb0225","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2337\/dc08-1529","article-title":"A-beta-subtype of ketosis-prone diabetes is not predominantly a monogenic diabetic syndrome","volume":"32","author":"Haaland","year":"2009","journal-title":"Diabetes Care"},{"key":"10.4158\/EP161679.RA_bb0230","first-page":"380","article-title":"Missense mutation Gly574Ser in the transcription factor HNF-1alpha is a marker of atypical diabetes mellitus in African-American children","volume":"42","author":"Boutin","year":"1999","journal-title":"Diabetologia"},{"key":"10.4158\/EP161679.RA_bb0235","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00125-003-1093-9","article-title":"The polymorphism Gly574Ser in the transcription factor HNF-1alpha is not a marker of adult-onset ketosis-prone atypical diabetes in Afro-Caribbean patients","volume":"46","author":"Mauvais-Jarvis","year":"2003","journal-title":"Diabetologia"},{"key":"10.4158\/EP161679.RA_bb0240","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/hmg\/ddh341","article-title":"PAX4 gene variations predispose to ketosis-prone diabetes","volume":"13","author":"Mauvais-Jarvis","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.4158\/EP161679.RA_bb0245","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1463-1326.2007.00830.x","article-title":"Gender and neurogenin3 influence the pathogenesis of ketosis-prone diabetes","volume":"10","author":"Louet","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP161679.RA_bb0250","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1210\/jc.2004-2545","article-title":"High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes","volume":"90","author":"Sobngwi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161679.RA_bb0255","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.diabet.2014.07.002","article-title":"Hyperglycaemia per se does not affect erythrocyte glucose-6-phosphate dehydrogenase activity in ketosis-prone diabetes","volume":"41","author":"Choukem","year":"2015","journal-title":"Diabetes Metab"},{"key":"10.4158\/EP161679.RA_bb0260","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1463-1326.2010.01254.x","article-title":"Initial short-term intensive insulin therapy as a strategy for evaluating the preservation of beta-cell function with oral antidiabetic medications: a pilot study with sitagliptin","volume":"12","author":"Retnakaran","year":"2010","journal-title":"Diabetes Obes Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:04:03Z","timestamp":1761516243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20358407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1530891X20358407"],"URL":"https:\/\/doi.org\/10.4158\/ep161679.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic Ketoacidosis: A Common Debut of Diabetes Among African Americans With Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP161679.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}